Klinik-Team

Publikationen in Peer reviewed Journals:

• Bohl, S., S. von Harsdorf, M. Mulaw, S. Hofmann, A. Babiak, C. P. Maier, J. Schnell, L. M. Hutter-Kronke, K. Scholl, V. Wais, R. F. Schlenk, L. Bullinger, M. Ringhoffer, H. Dohner, D. Bunjes, M. Bommer and F. Kuchenbauer (2016). "Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT." Bone Marrow Transplant.
• Bohl, S. R., F. Kuchenbauer, S. von Harsdorf, N. Kloevekorn, S. S. Schonsteiner, A. Rouhi, P. Schwarzwalder, H. Dohner, D. Bunjes and M. Bommer (2017). "Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation - a Comparison of Eculizumab Therapy and Conventional Therapy." Biol Blood Marrow Transplant.
• Bommer, M. and L. Bullinger (2016). "Meningeal carcinomatosis." Der Onkologe22(5): 321-328.
• Gröschel, S., M. Bommer, B. Hutter, J. Budczies, D. Bonekamp, C. Heining, P. Horak, M. Fröhlich, S. Uhrig, D. Hübschmann, C. Geörg, D. Richter, N. Pfarr, K. Pfütze, S. Wolf, P. Schirmacher, D. Jäger, C. von Kalle, B. Brors, H. Glimm, W. Weichert, A. Stenzinger and S. Fröhling (2016). "Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification." Molecular Case Studies.
• Kaltenmeier, C., A. Gawanbacht, T. Beyer, S. Lindner, T. Trzaska, J. A. van der Merwe, G. Harter, B. Gruner, D. Fabricius, R. Lotfi, K. Schwarz, C. Schutz, M. Honig, A. Schulz, P. Kern, M. Bommer, H. Schrezenmeier, F. Kirchhoff and B. Jahrsdorfer (2015). "CD4+ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patients." J Immunol194(8): 3768-3777.
• Peyvandi, F., M. Scully, J. A. Kremer Hovinga, S. Cataland, P. Knobl, H. Wu, A. Artoni, J. P. Westwood, M. Mansouri Taleghani, B. Jilma, F. Callewaert, H. Ulrichts, C. Duby, D. Tersago and T. Investigators (2016). "Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura." N Engl J Med374(6): 511-522.
• Thierauf, J., J. Lindemann, M. Bommer, J. A. Veit and T. K. Hoffmann (2015). "[Value of fine needle aspiration cytology and core needle biopsy in the head and neck region]." Laryngorhinootologie94(5): 311-316.
• Thierauf, J., J. A. Veit, J. Hess, N. Treiber, C. Lisson, S. E. Weissinger, M. Bommer and T. K. Hoffmann (2017). "Checkpoint inhibition for advanced mucosal melanoma." Eur J Dermatol.
• Wehling, C., O. Amon, M. Bommer, B. Hoppe, K. Kentouche, G. Schalk, R. Weimer, M. Wiesener, B. Hohenstein, B. Tonshoff, R. Buscher, H. Fehrenbach, O. N. Gok and M. Kirschfink (2016). "Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders." Clin Exp Immunol.
• Wunderlich, A. P., H. Cario, M. Bommer, M. Beer, S. A. Schmidt and M. S. Juchems (2016). "MRI-Based Liver Iron Content Determination at 3T in Regularly Transfused Patients by Signal Intensity Ratio Using an Alternative Analysis Approach Based on R2* Theory." Rofo188(9): 846-852.